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A B S T R A C T
Relatively few cases of Epstein-Barr (EBV)-positive B-cell lymphomas arising in patients with angioimmunoblastic
T-cell lymphoma (AITL) have been reported. We report a case of AITL in which diffuse large B-cell lymphoma arose 13
months after the initial diagnosis of AITL. In a 36-year-old female patient, evaluated for moderate leukocytosis, periph-
eral and abdominal lymphadenopathy AITL was diagnosed in March 2008, based on results of fine-needle aspiration cy-
tology (FNAC) of the enlarged cervical and supraclavicular lymph nodes.The diagnosis was also confirmed by immuno-
phenotyping and histopathology of the cervical lymph nodes. The patient initially recieved FED chemotherapy (flu-
darabine, cyclophosphamide, dexamethasone) followed by elective autologous hematopoietic stem cell transplantation.
In April 2009 the patient was hospitalized because of fever, pancytopenia, hyperbilirubinemia and peripheral lympha-
denopathy. The FNAC of the enlarged cervical lymph nodes was performed again, but this time the smears were com-
posed of polymorphous population of lymphocytes with the predomination of large cells, CD20+ on immunocytochemical
stains. The immunophenotyping confirmed a predomination of monoclonal mature B-cells. Patient had high number of
EBV DNA copies in plasma and serologic testing revealed increased titers of EBV VCA IgG and EBV EBNA IgG. CHOP-
-R chemotherapy (cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab) was then administered, re-
sulting in good partial response of the disease. Reduced intensity allogeneic stem cell transplantation performed thereaf-
ter, resulted in complete remission of the disease. AITL is a rare lymphoproliferative disorder in which the neoplastic
T-cells represent the minority of the lymph node cell population and almost all cases harbor EBV-infected B-cells. Vari-
ous authors postulated that immunodeficiency in AITL patients together with immunosupresive effects of cytotoxic
drugs, may be responsible for EBV-induced proliferation of latently or newely EBV-infected B-cells with eventual clonal
selection and progression to aggressive B-cell lymphoma.
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Introduction
We report a case of angioimmunoblastic T-cell lym-
phoma (AITL) in which diffuse large B-cell lymphoma
(DLBCL) arose 13 months after the initial diagnosis of
AITL.
Angioimmunoblastic T-cell lymphoma is a systemic
lymphoproliferative disorder that produces constitutio-
nal symptoms, generalized lymphadenopathy, hepatosple-
nomegaly, skin rash and immunological disturbances with
the overall median survival less than 3 years1–5. AITL pa-
tients tend to be severely immunodeficient and have a
propensity for opportunistic infections1–5 prior to and
during therapy6. Histologically, the involved lymph nodes
demonstrate partial to complete effacement of the nor-
mal arhitecture with atretic or absent germinal centers,
prominent neovascularization and polymorphous infil-
tration by plasma cells and immunoblasts7. Early disease
is often associated with intact and sometimes hyperpla-
stic germinal centers8. While peripheral sinuses are typi-
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cally open and even dilated, the abnormal infiltrate often
extends beyond the capsule8. Another prominent feature
is extensive arborization of post capillary venules which
lie in an expanded meshwork of follicular dendritic cells8.
Large basophilic B immunoblast and polyclonal plasma
cells are observed in the parafollicular areas in 25–80% of
patients and these B-cells often harbour Epstein-Barr vi-
rus (EBV)8,9.
The neoplastic T-cells represent a minority of the
lymph node cell population10. Almost all cases harbor an
EBV-infected B-cell population10 detected by polymerase
chain reaction (PCR) or fluorescent in situ hybridization
(FISH) analysis6. EBV driven B-lymphoid proliferation
may occur, analogous to immunodeficiency states such as
primary immune disorders, human immunodeficiency vi-
rus (HIV) infection and postallogenic organ transpla-
tation11. Relatively few cases of EBV-positive B-cell
lymphomas arising in patients with AITL have been
reported12–14.
Case Report
A 36-year-old female patient was evaluated in March
and April 2008 for mild leukocytosis (10.88´109/L), left
inguinal and cervical lymphadenopathy and edematous
left leg. In her medical history, she had infectious mono-
nucleosis 5-years ago. An enzyme immunoassay (EIA)
test for HIV infection was done and it was negative. After
an ultrasound examination showed enlarged left paraao-
rtal, mesenteric and left iliac lymph nodes, lymphopro-
liferative disease was suspected. Fine-needle aspiration
cytology (FNAC) of the enlarged inguinal and cervical
lymph nodes was performed. The yielded material was
placed and smeared on the slides, air-dried and May-
-Grünwald-Giemsa (MGG) stained. Immunocytochemi-
cal stains were done too. The cytology smears were com-
posed of a polymorphous population of the small lympho-
cytes (partially CD20+, and partially CD3+) with many
transformed lymphatic cells, immunoblasts and plas-
mablasts (Figures 1 and 2), which were CD3+. The cyto-
logical diagnosis was non-Hodgkin’s lymphoma (NHL) –
AITL. An immunophenotyping confirmed abnormal phe-
notype of the mature T-cells: CD2+, CD5+, CD7+, CD4+,
HLA D/DR+, CD38–/+ and CD3–, CD8–. A computed to-
mography (CT) study showed enlarged abdominal lymph
nodes in paraaortal and paracaval region with the largest
diameter of the single lymph node 35 mm; in the left iliac
region conglomerates of enlarged lymph nodes 50x35
mm in size were found; in the left pelvic region the con-
glomerates of enlarged nodes were 88x35 mm in size and
in the left inguinal region the largest lymph node was 25
mm in diameter. Liver and spleen were of normal size.
Biopsy of an enlarged left cervical lymph node was per-
formed. Microscopically, the lymph node architecture
was effaced and a polymorphic infiltrate composed of
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Fig. 1, 2. Polymorphous population of the small lymphocytes with
transformed lymphatic cells, immunoblasts and plasmablasts at
the first diagnosis (May-Grünwald-Giemsa, x100).
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small to medium-sized lymphoid cells with a clear cyto-
plasm and expansion of immunoblasts and plasma cells
was found. On immunohistochemical stains, the infil-
trating lymphoid cells were CD2+, CD7+, CD3+ and
CD4+ T-cells. There was marked proliferation of arbo-
rizing high endothelial venules (HEV). The diagnosis of
angioimmunoblastic T-cell lymphoma was revealed. Bone
marrow biopsy showed no bone marrow involvement.
The patient was treated with FED chemotherapy (flu-
darabine, cyclophosphamide, dexamethasone) followed
by elective autologous hematopoietic stem cell transplan-
tation in November 2008. In April 2009 the patient was
hospitalized because of fever, pancytopenia, hyperbili-
rubinemia (27 umol/L) and peripheral lymphadenopathy.
A relapse of non-Hodgkin’s lymphoma was suspected. A
thoracic CT study showed enlarged lymph nodes in the
upper mediastinum and in the left axillary region. An ab-
dominal ultrasound examination showed enlarged lymph
nodes in the paraaortal and mesenteric regions, 30 mm
in the largest diameter and enlarged spleen 150´50 mm
in size. The FNAC of the enlarged cervical and supra-
clavicular lymph nodes was performed again. This time,
the smears were composed of a polymorphous population
of small, medium-sized and large lymphocytes (Figures 3
and 4), predominately CD20+ (Figures 5 and 6) and the
minority of CD3+ cells. Large lymphocytes were CD3
negative on immunocytochemical stains (Figure 8). The
minor part of the large cells was weakly CD30+ (Figure
7) The cytological diagnosis was NHL-DLBCL. Immuno-
phenotyping confirmed a predomination of mature B-
-cells: CD45+, CD19+, CD79b+, CD20+, HLA D/DR+
with monoclonal expression of the lambda light chain of
immunoglobulins, with middle intensity of expression. A
mild infiltration of the bone marrow in bone marrow as-
pirate smears was confirmed. Autoimmune hemolytic
anemia and immunothrombocytopenia were detected.
Lactat dehydrogenase level was increased (967 U/L). Pa-
tient had high number of EBV DNA copies in plasma
(1,610,000 copies/mL) and serologic testing revealed in-
creased titers of EBV VCA IgG of 96 AU/mL and 55
AU/mL for EBNA IgG. A cycle of CHOP-R chemo-im-
munotherapy (cyclophosphamide, doxorubicin, vincristi-
ne, prednisone and rituximab) was administered. The
clinical course following chemotherapy was complicated
with pancytopenia, fever, mucositis and herpetic changes
on the skin, need for transfusional support and anti-
microbial therapy but the treatment resulted in regres-
sion of peripheral and abdominal lymphadenopathy. The-
refore, she received additional 3 cycles of CHOP-R ther-
apy and a very good partial response was achieved. Re-
duced intensity conditioning allogeneic stem cell trans-
plantation was performed thereafter, in August 2009,
and it resulted in complete remission of the disease.
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Fig. 5, 6. Large cells lymphoid CD20 positive on immunocyto-
chemical stains at relapse.
6
5
Fig. 7. Large lymphoid cells weakly CD30 positive on immuno-
cytochemical stains at relapse.
Fig. 8. Large lymphoid ells CD3 negative on immunocytochemi-
cal stains at relapse.
Discussion
Angioimmunoblastic T-cell lymphoma (AITL) is a ra-
re and aggressive neoplasm clinically characterised by
sudden onset of constitutional symptoms, lymphadeno-
pathy, hepatosplenomegaly, frequent autoimmune phe-
nomena, particularly hemolytic anemia and thrombo-
cytopenia and polyclonal hypergammaglobulinemia10. In
our case, the patient presented with mild leukocytosis
and peripheral lymphadenopathy. AITL is one of the
most common specific subtypes of peripheral T-cell lym-
phomas, accounting for approximately 15–20% of cases,
or 1–2% of all non-Hodgkin lymphomas11. AITL occurs in
the middle-aged and elderly, with an equal incidence in
males and females11. The median survival of AITL pa-
tients has been estimated to be between 11 and 30
months11. More than 75% of AITL patients present with
generalized lymphadenopathy15. Extranodal involvement
is common and typically manifests as hepatosplenome-
galy, bone marrow involvement and pleural and peri-
cardial effusions. A skin rash is frequently present16. The
presence of immunologic derangements is a hallmark of
AITL, often presenting as polyclonal hypergammaglobu-
linemia, Coombs positive autoimmune hemolytic ane-
mia, cold agglutinins, as well as a number of other immu-
nologic derangements including polyarthritis and thyroid
disease17. Despite the presence of this immune hyperac-
tivity, AITL patients often exhibit immunodeficiency and
a propensity for opportunistic infections5 prior to and
during therapy6. In most cases, the neoplastic T-cells ac-
count for a small fraction of the infiltrate, varying from 5
to 30%6, express pan T-cell antigens such as CD3, CD2,
CD5, in vast majority of the cases CD4 and characteristi-
cally CD102,11,18. Molecular studies of the T-cell receptor
(TCR) have demonstrated that the vast majority (90%)
have biased TCR rearrangements, with more than 75%
of cases showing monoclonal pattern and 14% an oli-
goclonal one19. It is unclear whether these cases lack
lymphocytic infiltrates, or whether they represent false
negative results because of limited sensitivity of the
Southern blot and PCR techniques applied10. Molecular
studies also showed the presence of biased immunoglob-
ulin (Ig) H rearrangements in AITL, with 30–35% show-
ing clonal patterns20. These rearranged IgH loci fre-
quently occur in EBV-infected B-cells that exhibit ongoing
somatic hypermutation, suggesting a germinal center
B-cell derivation21. Furthermore, these unique B-cell
clones not only survive, but they proliferate and expand
alongside the clonal T-cell proliferation despite the fre-
quent acquisition of crippling Ig mutations rendering
them Ig-receptor deficient21. EBV-positive B-cells are
nearly always present. They range in cell size and expan-
sion of B immunoblasts may be prominent, usually pres-
ent in the paracortex. The EBV-positive B immunoblastic
proliferation may progress, either composite with AITL,
or at relapse to EBV-positive DLBCL as in other immu-
nodeficiency states, such as HIV infection and post allo-
geneic organ transplantation11. However, relatively few
cases of EBV-positive B-cell lymphomas arising in pa-
tients with AITL have been reported. B-cell lymphomas
developed between 8 months and 10 years after the ini-
tial diagnosis of AITL5,12–14. In the presented case the pa-
tient developed DLBCL 13 months after the initial diag-
nosis of AITL. Various authors postulated that immuno-
deficiency in AITL patients together with the immuno-
suppressive effects of cytotoxic drugs, may be responsible
for EBV-induced proliferation of latently or newly EBV-
-infected B-cells with eventual clonal selection and pro-
gression to aggressive B-cell lymphoma12–14. In this case,
cytotoxic drugs together with immunodeficient status of
the patient have probably severely aggravated the al-
ready present immunodeficiency. According to some au-
thors, plasma EBV viral load correlates with histological
progression of AITL22. PCR of EBV DNA confirmed the
infection with high viral load in the presented case and
progression of AITL to DLBCL was confirmed after the
FNAC of the peripheral lymph node and immunophe-
notyping were done. Therefore, we suggest EBV viral
load monitoring together with performance of repeated
FNAC of enlarged lymph nodes for patients affected by
AITL in the course of the disease for an early detection of
the possible progression to secondary lymphomas.
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DIFUZNI B VELIKOSTANI^NI LIMFOM KOD PACIJENTICE NAKON TERAPIJE
ANGIOIMUNOBLASTI^NOG T LIMFOMA
S A @ E T A K
Relativno malo slu~ajeva Epstein-Barr virus (EBV) pozitivnih B stani~nih limfoma nastalih kod pacijenata s angio-
imunoblasti~nim T limfomom (AITL) je objavljeno. Opisujemo slu~aj AITL-a kod kojeg je difuzni B velikostani~ni lim-
fom nastao 13 mjeseci nakon prvotne dijagnoze AITL-a. Kod 36-godi{nje pacijentice s umjerenom leukocitozom, pe-
rifernom i abdominalnom limfadenopatijom u o`ujku 2008. godine dijagnosticiran je AITL nakon citolo{ke punkcije
pove}anih cervikalnih i supraklavikularnih limfnih ~vorova. Dijagnoza je potvr|ena imunofenotipizacijom i biopsijom
cervikalnih limfnih ~vorova. Pacijentica je lije~ena kemoterapijom po shemi FED (fludarabin, ciklofosfamid, deksa-
metazon) te joj je u~injena elektivna transplantacija autolognih krvotvornih mati~nih stanica. U travnju 2009. godine
pacijentica je hospitalizirana zbog vru}ice, pancitopenije, hiperbilirubinemije i periferne limfadenopatije. Citolo{ka
punkcija pove}anih cervikalnih limfnih ~vorova je ponovo ura|ena, ali ovaj put u razmazima je na|ena polimorfna
populacija limfocita s predominacijom velikih stanica, imunocitokemijski CD20+. Imunofenotipizacija je potvrdila pre-
dominaciju monoklonalnih zrelih B stanica. Razina EBV DNA u plazmi bila je vrlo visoka, a serolo{kim je testiranjem
dokazan povi{en titar EBV VCA IgG i EBV EBNA IgG. Pacijentica je lije~ena imunokemoterapijom CHOP-R (ciklo-
fosfamid, doksorubicin, vinkristin, prednizon i rituksimab) na koju je postignut vrlo dobar odgovor, a transplantacijom
alogenih krvotvornih mati~nih stanica nakon kondicioniranja smanjenog intenziteta postignuta je kompletna remisija.
AITL je rijedak limfoproliferativni poreme}aj kod kojeg neoplasti~ne T stanice ~ine manjinu populacije limfnog ~vora i
u skoro svim slu~ajevima postoje EBV-om inficirane B stanice. Razli~iti autori pretpostavljaju da imunodeficijencija kod
pacijenata s AITL-om zajedno s imunosupresivnim u~inkom citotoksi~nih lijekova bi mogla biti odgovorna za EBV-om
induciranu proliferaciju latentno ili novoinficiranih B stanica uz eventualnu klonalnu selekciju i progresiju u agresivni
B-stani~ni limfom.
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